Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

4724 ARTÍCULOS , VIENDO DEL 811 AL 825

α-Synuclein: A Multifunctional Player in Exocytosis, Endocytosis, and Vesicle Recycling

Huang M, Wang B, Li X, Fu C, Wang C, Kang X.

Front Neurosci. 2019 Jan 28;13:28. doi: 10.3389/fnins.2019.00028. eCollection 2019.

Mitochondrial integrity in neurodegeneration

Cowan K, Anichtchik O, Luo S.

CNS Neurosci Ther. 2019 Jul;25(7):825-836. doi: 10.1111/cns.13105. Epub 2019 Feb 11.

PAK4 signaling in health and disease: defining the PAK4-CREB axis

Won SY, Park JJ, Shin EY, Kim EG.

Exp Mol Med. 2019 Feb 12;51(2):1-9. doi: 10.1038/s12276-018-0204-0.

Nucleic Acid-Based Therapeutics for Parkinson's Disease

Nakamori M, Junn E, Mochizuki H, Mouradian MM.

Neurotherapeutics. 2019 Apr;16(2):287-298. doi: 10.1007/s13311-019-00714-7.

Dopamine in psychiatry: a historical perspective

Foley PB.

J Neural Transm (Vienna). 2019 Apr;126(4):473-479. doi: 10.1007/s00702-019-01987-0. Epub 2019 Feb 13.

Agomelatine for depression: expanding the horizons?

Norman TR, Olver JS.

Expert Opin Pharmacother. 2019 Apr;20(6):647-656. doi: 10.1080/14656566.2019.1574747. Epub 2019 Feb 13.

Impulsivity across reactive, proactive and cognitive domains in Parkinson's disease on dopaminergic medication: Evidence for multiple domain impairment

Canário N, Sousa M, Moreira F, Duarte IC, Oliveira F, Januário C, Castelo-Branco M.

PLoS One. 2019 Feb 13;14(2):e0210880. doi: 10.1371/journal.pone.0210880. eCollection 2019.

Non-Cell-Autonomous Neurotoxicity in Parkinson's Disease Mediated by Astroglial α-Synuclein

Chai M, Kohyama J.

Stem Cell Reports. 2019 Feb 12;12(2):183-185. doi: 10.1016/j.stemcr.2019.01.011.

Measuring network disruption in neurodegenerative diseases: New approaches using signal analysis

McMackin R, Muthuraman M, Groppa S, Babiloni C, Taylor JP, Kiernan MC, Nasseroleslami B, Hardiman O.

J Neurol Neurosurg Psychiatry. 2019 Sep;90(9):1011-1020. doi: 10.1136/jnnp-2018-319581. Epub 2019 Feb 13.

Can the Latest Computerized Technologies Revolutionize Conventional Assessment Tools and Therapies for a Neurological Disease? The Example of Parkinson's Disease

Asakawa T, Sugiyama K, Nozaki T, Sameshima T, Kobayashi S, Wang L, Hong Z, Chen S, Li C, Namba H.

Neurol Med Chir (Tokyo). 2019 Mar 15;59(3):69-78. doi: 10.2176/nmc.ra.2018-0045. Epub 2019 Feb 13.

Transmission of α-synuclein seeds in neurodegenerative disease: recent developments

Karpowicz RJ Jr, Trojanowski JQ, Lee VM.

Lab Invest. 2019 Jul;99(7):971-981. doi: 10.1038/s41374-019-0195-z. Epub 2019 Feb 13.

Role of Soluble Epoxide Hydrolase in Metabolism of PUFAs in Psychiatric and Neurological Disorders

Hashimoto K.

Front Pharmacol. 2019 Jan 30;10:36. doi: 10.3389/fphar.2019.00036. eCollection 2019.

Dementia spectrum disorders: lessons learnt from decades with PET research

Wilson H, Pagano G, Politis M.

J Neural Transm (Vienna). 2019 Mar;126(3):233-251. doi: 10.1007/s00702-019-01975-4. Epub 2019 Feb 14.

Unravelling protein aggregation as an ageing related process or a neuropathological response

Trigo D, Nadais A, da Cruz E Silva OAB.

Ageing Res Rev. 2019 May;51:67-77. doi: 10.1016/j.arr.2019.02.001. Epub 2019 Feb 11.

Vitamin D receptor polymorphisms and the susceptibility of Parkinson's disease

Wang X, Shen N, Lu Y, Tan K.

Neurosci Lett. 2019 Apr 23;699:206-211. doi: 10.1016/j.neulet.2019.02.018. Epub 2019 Feb 11.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias